CLINICAL_TRIALS
trial_result
· 2016-02-03
Clinical Trial Update: A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects [Phase 3]
Summary
A Phase 3 study of levalbuterol tartrate HFA inhalation aerosol in pediatric asthma was terminated, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma America, Inc. | Conditions: Asthma | Phase 3 | Status: TERMINATED | Results posted: 2016-02-03